Negraschusl, A; Holtermann, A; Edelmann, S; Rupp, L; Füchsl, F; Krackhardt, A; Schmitz, M; Kobold, S; Heissmeyer, V. (2024) MALT1-induced Roquin cleavage in T cells and CAR T cells is critical for anti-tumor immunity by TUMbrandherde | Jun 4, 2025
Thiel, U; von Heyking, K; Xue, BS; Gassmann, H; Thiede, M; Schober, K; Mautner, J; Hauer, J; Ruland, J; Busch, DH; Burdach, SEG (2024) T CELLS DIRECTED AGAINST THE METASTATIC DRIVER CHONDROMODULIN-1 IN EWING SARCOMA: COMPARATIVE ENGINEERING WITH CRISPR/CAS9 VS. RETROVIRAL GENE TRANSFER FOR ADOPTIVE TRANSFER by TUMbrandherde | Jun 4, 2025
Cai, C; Keoshkerian, E; Wing, K; Samir, J; Effenberger, M; Schober, K; Bull, RA; Lloyd, AR; Busch, DH; Luciani, F. (2024) Discovery of a monoclonal, high-affinity CD8+ T-cell clone following natural hepatitis C virus infection by TUMbrandherde | Jun 4, 2025
Maerkl, F; Schultheiss, C; Ali, M; Chen, SS; Zintchenko, M; Egli, L; Mietz, J; Chijioke, O; Paschold, L; Spajic, S; Holtermann, A; Doerr, J; Stock, S; Zingg, A; Laeubli, H; Piseddu, I; Anz, D; Minden, MDV; Zhang, TJ; Nerreter, T; Hudecek, M; Minguet, S; Chiorazzi, N; Kobold, S; Binder, M. (2024) Mutation-specific CAR T cells as precision therapy for IGLV3-21R110 expressing high-risk chronic lymphocytic leukemia by TUMbrandherde | Jun 4, 2025
Mühlgrabner, V; Peters, T; Cárdenas, RMHV; Salzer, B; Göhring, J; Plach, A; Höhrhan, M; Perez, ID; Goncalves, VD; Farfán, JS; Lehner, M; Stockinger, H; Schamel, WW; Schober, K; Busch, DH; Hudecek, M; Dushek, O; Minguet, S; Platzer, R; Huppa, JB (2024) TCR/CD3-based synthetic antigen receptors (TCC) convey superior antigen sensitivity combined with high fidelity of activation by TUMbrandherde | Jun 4, 2025
